<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04160325</url>
  </required_header>
  <id_info>
    <org_study_id>jinlingH201709</org_study_id>
    <nct_id>NCT04160325</nct_id>
  </id_info>
  <brief_title>Effect of the Exclusive Enteral Nutrition Combined With Azathioprine for Remission of Crohn's Diseases After Surgery</brief_title>
  <official_title>The Effect of the Exclusive Enteral Nutrition Combined With Azathioprine in Maintaining Remission of Patients With Crohn's Diseases After Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhu Weiming</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sixth Affiliated Hospital, Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sir Run Run Shaw Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Anhui Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Tsinghua Changgung Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Jinling Hospital, China</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      for some patients with Crohn's diseases undergoing surgery，whether exclusive enteral
      nutrition(EEN) could delay the disease relapse needs exploration.The trial will study whether
      the efficacy of postoperative EEN could help keeping remission.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For patients with Crohn's disease(CD), whether exclusive enteral nutrition(EEN) following
      bowel resection and anastomosis could delay the disease recurrence remains unkown. In this
      study， CD patients after surgery will be divided into two groups: one group is treated with 3
      months' EEN and then turn to normal diet after 3 months; the other group is given with normal
      diet all through. All patients will be adminstrated with oral azathioprine after surgery.
      Then, the rates of 1 year postoperative endoscopic recurrence will be compared between
      groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 14, 2018</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the 1 year postoperative anastomotic recurrence</measure>
    <time_frame>1 year</time_frame>
    <description>the 1 year postoperative anastomotic recurrence</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">198</enrollment>
  <condition>Crohn Disease</condition>
  <arm_group>
    <arm_group_label>3 months exclusive enteral nutrition plus azathioprine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients underwent surgery in this arm will given 3 months exclusive enteral nutrition,and free diet after 3 months. All patients will be adminsrated with oral azathioprine to preventing disease recurrence.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal diet plus azathioprine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients underwent surgery in this arm will given free diet all through. All patients will be adminsrated with oral azathioprine to preventing disease recurrence.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>postoperative 3-month exclusive enteral nutrition</intervention_name>
    <description>postoperative 3-month exclusive enteral nutrition after surgery and alter to normal food after 3 months</description>
    <arm_group_label>3 months exclusive enteral nutrition plus azathioprine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>azathioprine</intervention_name>
    <description>azathioprine</description>
    <arm_group_label>3 months exclusive enteral nutrition plus azathioprine</arm_group_label>
    <arm_group_label>normal diet plus azathioprine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>normal diet</intervention_name>
    <description>normal diet</description>
    <arm_group_label>normal diet plus azathioprine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CD patients who undergoing bowel resection with anastomosis

        Exclusion Criteria:

          -  patients who had administered with immunomodulators or biological agents patients who
             were created stoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>weiming zhu</last_name>
    <phone>+86-025-80860036</phone>
    <email>juwiming@nju.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ming duan</last_name>
    <phone>+86-025-80860037</phone>
    <email>duanming1206@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of General Surgery, Jinling hosptal,Medical School of Nanjing University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weiming Zhu, PhD</last_name>
      <phone>86-25-80863736</phone>
      <email>juwiming@nju.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 3, 2019</study_first_submitted>
  <study_first_submitted_qc>November 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2019</study_first_posted>
  <last_update_submitted>November 12, 2019</last_update_submitted>
  <last_update_submitted_qc>November 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Jinling Hospital, China</investigator_affiliation>
    <investigator_full_name>Zhu Weiming</investigator_full_name>
    <investigator_title>Director, Head of General Surgery, Principal Investigator, Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Azathioprine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

